It's not worth $500 now, at least I don't believe it is. That is the value of a fully de-risked 2591 with approval and sales across all current indications. But you have to think 2591/NEU is still being mispriced here given what looks to be abnormally high chance of success in it's target indications based on what we know (or at least my perception of what we know ) and the relative near term start of this de-risking.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
NEU
neuren pharmaceuticals limited
Add to My Watchlist
11.1%
!
$13.93

It's not worth $500 now, at least I don't believe it is. That is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.93 |
Change
1.390(11.1%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.96 | $13.93 | $12.91 | $4.215M | 313.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 489 | $13.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.93 | 676 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 228 | 13.830 |
2 | 323 | 13.820 |
5 | 569 | 13.810 |
5 | 1336 | 13.800 |
3 | 552 | 13.790 |
Price($) | Vol. | No. |
---|---|---|
13.880 | 1801 | 3 |
13.890 | 244 | 2 |
13.900 | 6218 | 8 |
13.910 | 1133 | 3 |
13.920 | 591 | 3 |
Last trade - 10.29am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online